During the past decade, Presbyterian Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Medical Group" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Alliance Healthcare Foundation" with 1 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator and "Clovis Oncology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Medical Group" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non Small Cell Lung Cancer (NSCLC)" (1 trials), "Ovarian Neoplasm" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Presbyterian Medical Group" in a lesser frequency.

Most popular intervention types in "Presbyterian Medical Group" are "Drug" (6 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "BNC105P" (1 trials), "Cisplatin" (1 trials), "Erlotinib" (1 trials), "Everolimus" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Medical Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Presbyterian Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Presbyterian Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Medical Group, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Presbyterian Medical Group has several departments that took part in Clinical trials: "Presbyterian Rust Medical Center/Jorgensen Cancer Center" - 53 trials, "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" - 20 trials, "Presbyterian Heart Group" - 17 trials